肠道微生物群调节减轻糖尿病小鼠心肌缺血再灌注损伤
该研究以雄性db/db小鼠(2型糖尿病模型)为对象,经抗生素预处理后接受14天来自瘦型db/m供体的粪菌移植或溶媒,随后诱导心肌缺血再灌注损伤并量化梗死面积,同时用16S rRNA基因测序评估肠道菌群。结果显示,与IRI组相比,FMT组梗死面积占危险区的百分比显著降低(38.7 ± 13.4% vs. 58.7 ± 4.3%,P = 0.003)。菌群分析中,α多样性仅Simpson指数在供体与糖尿病组间存在差异,β多样性显示糖尿病小鼠与供体小鼠分开聚类,微生物干预引起Unweighted UniFrac presence/absence检测到的适度但显著的变化。差异丰度分析和探索性LEfSe进一步提示Akkermansia,尤其是A. muciniphila,为糖尿病小鼠中减少、FMT后部分恢复的候选菌种。
要点
- 在雄性db/db 2型糖尿病小鼠中,14天粪菌移植(来自瘦型db/m供体)使心肌缺血再灌注损伤后梗死面积占危险区百分比从58.7 ± 4.3%降至38.7 ± 13.4%(P = 0.003)。
- FMT干预后肠道菌群发生部分重塑:β多样性显示糖尿病小鼠与供体小鼠分开聚类,FMT引起Unweighted UniFrac presence/absence检测到的适度但显著变化。
- α多样性各指标中仅Simpson指数在供体与糖尿病组间存在差异。
- 差异丰度分析和探索性LEfSe提示Akkermansia(尤其A. muciniphila)在糖尿病小鼠中减少、FMT后部分恢复,为与IRI易感性降低相关的候选菌种。
- 该研究为动物实验,结论尚不能直接转化为糖尿病患者的临床实践。
适用人群与场景
- 雄性db/db小鼠(2型糖尿病模型),经抗生素预处理后接受干预。
处置流程与药物剂量
- 粪菌移植组:接受来自瘦型db/m供体的粪菌移植,疗程14天;对照组接受溶媒;两组均在抗生素预处理之后进行。
- 随后诱导心肌缺血再灌注损伤并量化梗死面积。
研究设计与关键结果
- 研究类型:动物实验(小鼠模型研究),样本量原文未报告;对象为雄性db/db小鼠(2型糖尿病模型)。
- 干预与对照:14天粪菌移植(来自瘦型db/m供体)vs 溶媒,均经抗生素预处理。
- 主要结果:FMT组梗死面积占危险区百分比为38.7 ± 13.4%,IRI组为58.7 ± 4.3%,FMT组显著降低(P = 0.003)。
- 菌群α多样性:仅Simpson指数在供体与糖尿病组间存在差异。
- 菌群β多样性:糖尿病小鼠与供体小鼠分开聚类;微生物干预引起Unweighted UniFrac presence/absence检测到的适度但显著变化。
- 差异丰度分析与探索性LEfSe提示Akkermansia(尤其A. muciniphila)在糖尿病小鼠中减少、FMT后部分恢复,为与IRI易感性降低相关的候选菌种。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为糖尿病小鼠模型中的动物实验,结果提示供体来源的微生物干预可减轻心肌缺血再灌注损伤并部分重塑肠道菌群,A. muciniphila为候选保护菌种,尚不能直接改变急诊或ICU临床实践。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The gut microbiome is increasingly being recognized as a regulator of cardiometabolic health; however, whether the microbiome interventions can attenuate myocardial ischemia-reperfusion injury (IRI) in diabetic hearts remains unclear. Therefore, we tested whether fecal microbiota transplantation (FMT) from lean nondiabetic donors could mitigate myocardial IRI in type 2 diabetes mellitus db/db mice and explored candidate taxa associated with protection.
METHODS: Male db/db mice (type 2 diabetes mellitus model) received a 14-day course of FMT from lean db/m donors or a vehicle after antibiotic pretreatment. Myocardial IRI was induced, and infarct size was quantified. The gut microbiota was evaluated by 16S rRNA gene sequencing.
RESULTS: FMT significantly reduced the infarct size as a percentage of the area at risk compared to the IRI group (38.7 ± 13.4% vs. 58.7 ± 4.3%, P = 0.003). Microbiome analysis revealed that among alpha-diversity metrics, only the Simpson index differed between the donor and diabetic groups. In beta-diversity analyses, diabetic mice clustered separately from donor mice, and the microbiome intervention induced a modest but significant shift detected by the presence or absence of Unweighted UniFrac. Differential abundance analysis and exploratory linear discriminant analysis effect size further suggested Akkermansia , particularly A. muciniphila , as a candidate taxon reduced in diabetic mice and partially restored after the FMT intervention.
CONCLUSION: A donor-derived microbiome intervention attenuated myocardial IRI in db/db mice and was accompanied by partial remodeling of the gut microbiota. A. muciniphila emerged as a candidate taxon associated with a reduced susceptibility to IRI in diabetic hearts.
参考来源
- Takahashi K, Yoshikawa Y, Chaki T, et al. Gut Microbiota Modulation Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetic Mice. Shock. 2026. PMID: 42275128. doi:10.1097/SHK.0000000000002882
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。